We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on promoting healthy and safe communities.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
The One Health Initiative seeks to promote, improve and defend the health and well-being of all species
How the UK supports the use of combined heat and power (CHP) or 'cogeneration', which avoids network losses and reduces emissions.
Information for healthcare professionals to protect the public from pressure ulcers (bed sores).
Guidance for EU exporters, exporters from rest of the world and UK importers, on how to import groupage or mixed load consignments of animal products into Great Britain (England, Scotland and Wales).
Experience from a field experiment in Kenya.
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
How to use a randomised controlled trial to evaluate your digital health product.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
White paper setting out legislative proposals for a Health and Care Bill.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).